Capricor Therapeutics-Wall Street Analysts Believe Capricor (CAPR) Could Rally 208.09%: Here's is How to Trade

Capricor Therapeutics (CAPR) closed the last trading session at $13.47, gaining 7.6% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by Wall Street analysts are any guide. The mean price target of$ 41.50 indicates a 208.1% upside potential.The mean estimate comprises six short-term price targets with a standard deviation of $18.52. While the lowest estimate of$ 25 indicates an 85.6% increase from the current price level, the most optimistic ana ...